8-K: Fortive Exceeds 2025 EPS Guidance, Initiates Strong 2026 Outlook

Fortive Corporation reported strong fourth quarter and full year 2025 financial results, surpassing adjusted diluted net EPS guidance and initiating a positive outlook for 2026.

Summary

• Fortive delivered full year 2025 GAAP diluted net EPS of $1.59 and adjusted diluted net EPS of $2.71, exceeding the high end of its guidance range.
• Fourth quarter 2025 reported revenue grew 4.6% year-over-year to $1.12 billion, with core revenue up 3.3%.
• Full year 2025 reported revenue increased 1.9% year-over-year to $4.16 billion, with core revenue up 1.7%.
• The company executed an incremental $265 million in share repurchases during Q4 2025, bringing total second half repurchases to approximately $1.3 billion, representing about 26 million shares or 8% of diluted shares outstanding.
• For the full year 2025, Fortive deployed $1.6 billion towards share repurchases.
• Fortive is initiating full year 2026 Adjusted EPS guidance of $2.90 to $3.00.
• The Intelligent Operating Solutions segment reported Q4 2025 revenue of $770 million, up 5.3% reported and 4.1% core, with Adjusted EBITDA up 7.6%.
• The Advanced Healthcare Solutions segment reported Q4 2025 revenue of $353 million, up 3.2% reported and 1.6% core, but saw GAAP Operating profit decline 9.6% and Adjusted EBITDA decline 2.6%.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong report, highlighted by exceeding full-year adjusted EPS guidance and robust share repurchase activity, signaling confidence in future performance despite some segment-specific softness.

Positives

• Full year 2025 adjusted diluted net EPS of $2.71 exceeded the high end of the company's guidance range.
• Strong Q4 2025 performance with approximately 3% core revenue growth, 8% Adjusted EBITDA growth, and 13% Adjusted EPS growth.
• Initiating a positive full year 2026 Adjusted EPS guidance of $2.90 to $3.00, indicating anticipated continued growth.
• Significant capital allocation towards share repurchases, totaling $1.6 billion in FY 2025, including $1.3 billion in the second half, demonstrating commitment to returning value to shareholders.
• Intelligent Operating Solutions segment showed robust growth in Q4 2025 with 4.1% core revenue growth and 7.6% Adjusted EBITDA growth.
• Full year 2025 GAAP net income increased 10.4% and GAAP diluted net EPS increased 16.1% year-over-year.

Negatives

• Q4 2025 GAAP net income decreased 0.9% year-over-year to $192 million.
• Q4 2025 GAAP net income margin declined by 90 basis points to 17.1%.
• Advanced Healthcare Solutions segment experienced a decline in Q4 2025 GAAP Operating profit by 9.6% and Adjusted EBITDA by 2.6%.
• Full year 2025 Free Cash Flow decreased 1.3% year-over-year to $931 million.

Risks

• Deterioration or instability in the economy, markets served, international trade policies, and trade relations.
• Impact of geopolitical conditions and conflicts, including war and sanctions.
• Security breaches, data exfiltration, or other disruptions of information technology systems.
• Supply chain constraints and the ability to adjust purchases and manufacturing capacity to market conditions.
• Reliance on sole sources of supply.
• Contractions or lower growth rates and cyclicality of markets served.
• Competition and changes in industry standards and governmental regulations.
• Ability to manage leadership transitions and recruit and retain key employees.
• Ability to successfully identify, consummate, integrate, and realize the anticipated value of acquisitions or effectively deploy capital.
• Potential for improper conduct by employees, agents, or business partners.
• Contingent liabilities relating to acquisitions and divestitures.
• Impact of changes to tax laws, compliance with regulations, and tax audits.
• Risks relating to potential impairment of goodwill and other intangible assets.
• Currency exchange rate fluctuations.
• Impact of debt obligations on operations.
• Litigation and other contingent liabilities, including intellectual property and environmental, health, and safety matters.
• Ability to adequately protect intellectual property rights.
• Risks relating to product, service, or software defects, product liability, and recalls.
• Risks relating to product manufacturing and relationships with channel partners.
• Commodity costs and surcharges.
• Adverse effects of restructuring activities.
• Risks related to the tax treatment of prior separations (Precision Technologies and Vontier).
• Impact of indemnification obligations to Ralliant and Vontier.
• Impact of changes to U.S. GAAP and labor matters.
• Disruptions relating to man-made and natural disasters and climate change.

Future Outlook

Fortive is initiating full year 2026 Adjusted diluted net earnings per share guidance of $2.90 to $3.00. The company remains focused on executing its 'Fortive Accelerated' strategy, which includes profitable organic growth acceleration powered by FBS Amplified, disciplined capital allocation, and a commitment to building investor trust. Management expresses strong conviction in delivering on its medium-term financial framework and realizing significant value creation.

Management Comments

• "Q4 represented another quarter of solid execution by our new Fortive team."
• "With the first two quarters of performance now behind us, and our 2026 strategic and financial plans firmly in place, our strong conviction in the road ahead continues to build."
• "In Q4, our team delivered results ahead of our expectations with ~3% core revenue growth, ~8% Adjusted EBITDA growth, and ~13% Adjusted EPS growth. This strong performance enabled us to exceed the high end of our full year Adjusted EPS guidance range."
• "We also continued to execute our disciplined, returns-focused capital allocation strategy, completing an additional $265 million of share repurchases in the quarter and bringing total second-half buybacks to ~$1.3 billion, said Olumide Soroye, President and CEO."
• "We remain laser-focused on executing the three elements of our Fortive Accelerated strategy: profitable organic growth acceleration powered by FBS Amplified, disciplined capital allocation, and a commitment to building investor trust."
• "While we are still early in our journey, the progress we are seeing reinforces our confidence in delivering on our medium-term financial framework and realizing the significant value creation opportunity ahead, Mr. Soroye concluded."

Industry Context

StockSavvy.ai notes that Fortive's focus on 'Intelligent Operating Solutions' and 'Advanced Healthcare Solutions' positions it in resilient and growing sectors. The emphasis on 'FBS Amplified' suggests a continued commitment to operational excellence and efficiency, a common theme among leading industrial technology companies aiming to drive organic growth and margin expansion. The significant share repurchases reflect a broader trend among mature, cash-generative companies to return capital to shareholders, especially when organic growth opportunities might be more measured.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess against global industry benchmarks.

Related Party Transactions

• A charitable donation of $20 million was pledged to the Fortive Foundation, a related party, during the first quarter of 2024.

Stakeholder Impact

• Shareholders: Benefited from strong adjusted EPS performance exceeding guidance and significant share repurchases, indicating management's commitment to shareholder returns. The positive 2026 guidance suggests continued value creation.
• Employees: Impacted by restructuring activities, with a discrete restructuring plan extended through H2 2026, which could lead to further workforce adjustments. The company's ability to recruit and retain key employees is noted as a risk.
• Customers: Benefit from the company's focus on essential technologies and continuous improvement through the Fortive Business System, but face risks related to product defects or service issues.
• Creditors: The company's debt obligations are noted as a risk factor, though strong cash flow generation helps manage this.

Next Steps

• Fortive will discuss results and outlook during its quarterly investor conference call on February 4, 2026, at 12:00 p.m. ET.
• Continue executing the 'Fortive Accelerated' strategy focusing on profitable organic growth acceleration, disciplined capital allocation, and building investor trust.
• Completion of the discrete restructuring plan related to the PT Separation is now expected by the second half of 2026.

Key Dates

Recommendation

Fortive's strong financial performance, particularly exceeding full-year adjusted EPS guidance and demonstrating robust core revenue growth in its Intelligent Operating Solutions segment, indicates operational strength. The significant share repurchase program underscores management's confidence and commitment to shareholder value. While the Advanced Healthcare Solutions segment showed some weakness and a restructuring plan was extended, the overall positive outlook for 2026, coupled with disciplined capital allocation, suggests a favorable investment opportunity for long-term growth.

Keywords

Fortive, FTV, Earnings, Financial Results, Q4 2025, Full Year 2025, Adjusted EPS, Revenue Growth, Share Repurchases, Intelligent Operating Solutions, Advanced Healthcare Solutions, Guidance, SEC Filing, 8-K